Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $17.75 in the prior trading day, Sabra Healthcare REIT Inc (NASDAQ: SBRA) closed at $17.50, down -1.41%. In other words, the price has decreased by -$1.41 from its previous closing price. On the day, 2.65 million shares were traded. SBRA stock price reached its highest trading level at $17.705 during the session, while it also had its lowest trading level at $17.47.
Ratios:
Our goal is to gain a better understanding of SBRA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 144.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.32. In the meantime, Its Debt-to-Equity ratio is 0.90 whereas as Long-Term Debt/Eq ratio is at 0.89.
On January 07, 2025, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $20.
Mizuho Downgraded its Outperform to Neutral on December 05, 2024, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 24 ’25 when Cusack Catherine bought 1,500 shares for $15.92 per share. The transaction valued at 23,880 led to the insider holds 60,583 shares of the business.
Cusack Catherine bought 1,000 shares of SBRA for $16,435 on Feb 21 ’25. The Director now owns 59,083 shares after completing the transaction at $16.43 per share. On May 22 ’24, another insider, Cusack Catherine, who serves as the Director of the company, bought 7,000 shares for $14.43 each. As a result, the insider paid 101,010 and bolstered with 46,385 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SBRA now has a Market Capitalization of 4163879936 and an Enterprise Value of 6527941120. As of this moment, Sabra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.62, and their Forward P/E ratio for the next fiscal year is 22.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.83 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 9.063 whereas that against EBITDA is 15.109.
Stock Price History:
The Beta on a monthly basis for SBRA is 0.83, which has changed by 0.20856357 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, SBRA has reached a high of $19.99, while it has fallen to a 52-week low of $13.81. The 50-Day Moving Average of the stock is 0.41%, while the 200-Day Moving Average is calculated to be 0.08%.
Shares Statistics:
The stock has traded on average 2.55M shares per day over the past 3-months and 2844840 shares per day over the last 10 days, according to various share statistics. A total of 237.94M shares are outstanding, with a floating share count of 233.63M. Insiders hold about 1.81% of the company’s shares, while institutions hold 96.70% stake in the company. Shares short for SBRA as of 1745971200 were 18577917 with a Short Ratio of 7.28, compared to 1743379200 on 19020978. Therefore, it implies a Short% of Shares Outstanding of 18577917 and a Short% of Float of 11.03.
Dividends & Splits
In the trailing 12 months, SBRA’s forward annual dividend rate was 1.2, compared to 1.20 this year. Against a Trailing Annual Dividend Yield of 0.06760564The stock’s 5-year Average Dividend Yield is 8.54. The current Payout Ratio is 223.55% for SBRA, which recently paid a dividend on 2025-02-14 with an ex-dividend date of 1747353600. Stock splits for the company last occurred on 2010-11-16 when the company split stock in a 1:3 ratio.
